Abstract: This application relates to the field of artificial intelligence technologies, and provides a feature map processing method and a related device. The method is implemented by invoking a neural network model that includes a plurality of input adaptation branches and a post-processing part. An output of each of the plurality of input adaptation branches is an input of the post-processing part, and each of the plurality of input adaptation branches can downsample a feature map at a different ratio.

Abstract: This application provides picture or audio encoding and decoding methods and apparatuses, and relates to the field of artificial intelligence (AI)—based picture or audio encoding and decoding technologies, and specifically, to the field of neural network-based picture feature map or audio feature variable encoding and decoding technologies. The encoding method includes: obtaining a to-be-encoded target, where the to-be-encoded target includes a plurality of feature elements, and the plurality of feature elements include a first feature element. The method further includes: obtaining a probability estimation result of the first feature element; determining, based on the probability estimation result of the first feature element, whether to perform entropy encoding on the first feature element; and performing entropy encoding on the first feature element only when it is determined that entropy encoding needs to be performed on the first feature element.

Abstract: Use of 9,10-anthraquinone compounds of formula (I) or pharmaceutical salts thereof or plant extracts containing said compounds in the preparation of anti-HCV medicaments is disclosed, in which Y1 are Y2 are independently hydrogen, hydroxyl or groups of formula (II); and R1, R2, R3, R4, R5 and R6 are independently hydrogen, hydroxyl, carboxyl, cyano group, nitro group, groups of formula (III) or groups selected from those substituted or unsubstituted groups: amino, C1-C6 aliphatic hydrocarbon, C3-C7 cyclic aliphatic hydrocarbon, C1-C6 alkoxy, C2-C7 carbalkoxy, C1-C4 acyloxy, C6-C20 aryl, or 5 to 7 members heterocyclic or benzoheterocyclic thereof; or R5 and R6 form the group of formula (IV). The compounds of present invention are cheap, safe and effective because that they mostly come from traditional Chinese medicines and have better anti-HCV effects and lighter side effects.

Abstract: Use of 9,10-anthraquinone compounds of formula (I) or pharmaceutical salts thereof or plant extracts containing said compounds in the preparation of anti-HCV medicaments is disclosed, in which Y1 are Y2 are independently hydrogen, hydroxyl or groups of formula (II); and R1, R2, R3, R4, R5 and R6 are independently hydrogen, hydroxyl, carboxyl, cyano group, nitro group, groups of formula (III) or groups selected from those substituted or unsubstituted groups: amino, C1-C6 aliphatic hydrocarbon, C3-C7 cyclic aliphatic hydrocarbon, C1-C6 alkoxy, C2-C7 carbalkoxy, C1-C4 acyloxy, C6-C20 aryl, or 5 to 7 members heterocyclic or benzoheterocyclic thereof; or R5 and R6 form the group of formula (IV). The compounds of present invention are cheap, safe and effective, because that they mostly conic from traditional Chinese medicines and have better anti-HCV effects and lighter side effects.